Shizhang Wei

2.8k total citations · 2 hit papers
87 papers, 2.1k citations indexed

About

Shizhang Wei is a scholar working on Pharmacology, Epidemiology and Molecular Biology. According to data from OpenAlex, Shizhang Wei has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmacology, 30 papers in Epidemiology and 26 papers in Molecular Biology. Recurrent topics in Shizhang Wei's work include Liver Disease Diagnosis and Treatment (24 papers), Drug Transport and Resistance Mechanisms (18 papers) and Pharmacological Effects of Natural Compounds (17 papers). Shizhang Wei is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Drug Transport and Resistance Mechanisms (18 papers) and Pharmacological Effects of Natural Compounds (17 papers). Shizhang Wei collaborates with scholars based in China, Hong Kong and Germany. Shizhang Wei's co-authors include Xiao Ma, Yanling Zhao, Yanling Zhao, Manyi Jing, Jianxia Wen, Haotian Li, Ruilin Wang, Xing Li, Wenwen Zhang and Xuelin Zhou and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Molecules.

In The Last Decade

Shizhang Wei

84 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis

2022 262 citations Xing Li, Shizhang Wei et al. profile →
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects

2021 171 citations Shizhang Wei, Xiao Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shizhang Wei China	29	894	667	429	349	271	87	2.1k
Yanling Zhao China	32	1.1k 1.2×	845 1.3×	380 0.9×	389 1.1×	384 1.4×	119	2.5k
Feifei Guo China	22	1.5k 1.7×	365 0.5×	423 1.0×	285 0.8×	197 0.7×	95	2.7k
Li‐Hua Lian China	31	1.0k 1.1×	540 0.8×	679 1.6×	264 0.8×	142 0.5×	96	2.4k
Xiaoying Wang China	26	1.1k 1.3×	527 0.8×	343 0.8×	454 1.3×	156 0.6×	98	2.8k
Shi-Bing Su China	30	1.3k 1.4×	563 0.8×	538 1.3×	428 1.2×	356 1.3×	125	2.9k
Ming Niu China	29	1.2k 1.3×	887 1.3×	393 0.9×	289 0.8×	127 0.5×	134	2.5k
Zhaofang Bai China	24	1.3k 1.4×	823 1.2×	315 0.7×	191 0.5×	153 0.6×	113	2.3k
Yanling Zhao China	22	848 0.9×	441 0.7×	292 0.7×	274 0.8×	103 0.4×	76	1.9k
Jianxia Wen China	21	514 0.6×	400 0.6×	231 0.5×	185 0.5×	222 0.8×	61	1.3k
Zhifeng Wei China	33	1.5k 1.7×	483 0.7×	214 0.5×	277 0.8×	198 0.7×	131	3.0k

Countries citing papers authored by Shizhang Wei

Since Specialization

Citations

This map shows the geographic impact of Shizhang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizhang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizhang Wei more than expected).

Fields of papers citing papers by Shizhang Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizhang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizhang Wei. The network helps show where Shizhang Wei may publish in the future.

Co-authorship network of co-authors of Shizhang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Shizhang Wei. A scholar is included among the top collaborators of Shizhang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizhang Wei. Shizhang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ying, et al.. (2025). Genomic Integration of Hepatitis B Virus Into Human Hepatocytes in Early Childhood Cirrhosis. Liver International. 45(4). e70080–e70080.

Wei, Shizhang, Lisheng Chen, Manyi Jing, et al.. (2024). The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury. Journal of Gastroenterology and Hepatology. 39(6). 1134–1144. 3 indexed citations

Wu, Wenbin, Yanling Sun, Xing Li, et al.. (2024). Integrated Microbiome and Metabolomic to Explore the Mechanism of Coptisine in Alleviating Ulcerative Colitis. Phytotherapy Research. 39(2). 676–697. 2 indexed citations

Chang, Lei, Lisheng Chen, Yong He, et al.. (2023). Integrated network pharmacology and metabolomics to investigate the effects and possible mechanisms of Dehydroevodiamine against ethanol-induced gastric ulcers. Journal of Ethnopharmacology. 319(Pt 3). 117340–117340. 11 indexed citations

Wei, Shizhang, Xu Zhao, Manyi Jing, et al.. (2023). Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice. Frontiers in Pharmacology. 14. 1197847–1197847. 10 indexed citations

Wei, Shizhang, et al.. (2023). Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. Frontiers in Immunology. 14. 1164202–1164202. 13 indexed citations

Chen, Lisheng, Shizhang Wei, Yong He, et al.. (2023). Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms. Pharmaceuticals. 16(9). 1308–1308. 13 indexed citations

Li, Xing, Shizhang Wei, Xiao Ma, et al.. (2021). Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 35 indexed citations

Chen, Lisheng, Shizhang Wei, Honghong Liu, et al.. (2021). Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 16 indexed citations

10.

Yang, Tao, Kaili Wang, Yibo Cao, et al.. (2021). Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis. BMJ Open. 11(2). e039461–e039461. 1 indexed citations

11.

Chen, Lisheng, Ruilin Wang, Honghong Liu, et al.. (2021). Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 10 indexed citations

12.

Niu, Ming, Ruisheng Li, Ruilin Wang, et al.. (2021). Mechanism of rutaecarpine on ethanol-induced acute gastric ulcer using integrated metabolomics and network pharmacology. Biomedicine & Pharmacotherapy. 138. 111490–111490. 35 indexed citations

13.

Wen, Jianxia, Lu Zhang, Jian Wang, et al.. (2020). Therapeutic effects of higenamine combined with [6]‐gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function. Journal of Cellular and Molecular Medicine. 24(7). 4036–4050. 39 indexed citations

14.

Chen, Xing, Ruilin Wang, Chunmei Bao, et al.. (2020). Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR. European Journal of Pharmacology. 882. 173267–173267. 28 indexed citations

15.

Wen, Jianxia, Ruilin Wang, Honghong Liu, et al.. (2020). Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review. Chinese Medicine. 15(1). 48–48. 8 indexed citations

16.

Xu, Zhuo, Haotian Li, Tao Wang, et al.. (2019). Antibacterial evaluation of plants extracts against ampicillin-resistant Escherichia coli (E. coli) by microcalorimetry and principal component analysis. AMB Express. 9(1). 13 indexed citations

17.

Wen, Jianxia, Jian Wang, Pengyan Li, et al.. (2019). Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms. Biomedicine & Pharmacotherapy. 115. 108881–108881. 32 indexed citations

18.

Wang, Dan, Ruisheng Li, Shizhang Wei, et al.. (2019). Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis. Chinese Medicine. 14(1). 30–30. 31 indexed citations

19.

Lu, Xiaohua, Lu Zhang, Jiabo Wang, et al.. (2018). Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis. Frontiers in Pharmacology. 9. 810–810. 17 indexed citations

20.

Ma, Xiao, Ming Niu, Yun Zhu, et al.. (2016). Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.. Frontiers in Pharmacology. 7. 14–14. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact